Pax Financial Group, LLC Biogen Inc. Transaction History

Pax Financial Group, LLC

$531 Million
Q3 2024

A detailed history of Pax Financial Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Pax Financial Group, LLC holds 1,963 shares of BIIB stock, worth $309,545. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,963

Previous 1,856 5.77%

Holding current value

$309,545

Previous $430,000 11.63%

% of portfolio

0.07%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $20,230 - $25,337	107 Added 5.77%	1,963 $380,000
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $18,480 - $22,961	-97 Reduced 4.97%	1,856 $430,000
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $33,075 - $41,762	156 Added 8.68%	1,953 $421,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $48,969 - $58,946	220 Added 13.95%	1,797 $465,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $11,398 - $12,865	45 Added 2.94%	1,577 $405,000
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $16,790 - $19,401	-61 Reduced 3.83%	1,532 $436,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $10,518 - $11,985	-41 Reduced 2.51%	1,593 $442,000
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $261,275 - $317,455	-1,035 Reduced 38.78%	1,634 $452,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $8,566 - $11,812	-44 Reduced 1.62%	2,669 $713,000
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $135,591 - $161,243	-723 Reduced 21.04%	2,713 $553,000
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $55,418 - $69,824	286 Added 9.08%	3,436 $724,000
Q4 2021 Feb 07, 2022	BUY	$223.92 - $287.77 $94,942 - $122,014	424 Added 15.55%	3,150 $756,000
Q3 2021 Oct 29, 2021	SELL	$282.99 - $369.05 $1,980 - $2,583	-7 Reduced 0.26%	2,726 $771,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $17,353 - $27,785	67 Added 2.51%	2,733 $946,000
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $121,232 - $142,030	499 Added 23.03%	2,666 $746,000
Q4 2020 Feb 03, 2021	BUY	$236.26 - $355.63 $81,982 - $123,403	347 Added 19.07%	2,167 $531,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $93,199 - $107,609	352 Added 23.98%	1,820 $516,000
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $63,630 - $84,267	246 Added 20.13%	1,468 $393,000
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $81,730 - $103,676	304 Added 33.12%	1,222 $364,000
Q4 2019 Feb 21, 2020	BUY	$220.06 - $304.07 $202,015 - $279,136	918 New	918 $309,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.

Account

Pax Financial Group, LLC Biogen Inc. Transaction History